PKI-166

• Description:

  PKI-166 is an oral inhibitor of EGF-R tyrosine kinase (IC50:0.7 nM) that is both effective and selective. PKI-166 can effectively inhibit the growth and metastasis of various human cancer cells including pancreatic cancer.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  330.38

• Molecular Formula:

  C20H18N4O

• Notes:

  Research use only, not for human use.

• Receptor:

  VEGFR

• CAS Number:

  187724-61-4